We are live on
!
Find out more
PAMU
Pictet Asset Management (UK) Portfolio holdings
AUM
$91.8B
1-Year Est. Return
47.77%
This Fund
S&P 500
This Quarter
Est. Return
+1.02%
1 Year Est. Return
+47.77%
3 Year Est. Return
+102.96%
5 Year Est. Return
+189.45%
10 Year Est. Return
–
AUM
$40.5B
AUM Growth
+$1.67B
(+4.3%)
Cap. Flow
+$1.77B
Cap. Flow
% of AUM
4.37%
Top 10 Holdings %
Top 10 Hldgs %
11.99%
Holding
924
New
37
Increased
379
Reduced
384
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$154M |
| 2 |
PayPal
PYPL
|
+$129M |
| 3 |
WP
Worldpay, Inc.
WP
|
+$119M |
| 4 |
Union Pacific
UNP
|
+$105M |
| 5 |
Meta Platforms (Facebook)
META
|
+$82.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Southern Company
SO
|
+$105M |
| 2 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$92.4M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$88.9M |
| 4 |
Intel
INTC
|
+$71.2M |
| 5 |
Amazon
AMZN
|
+$58.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.01% |
| 2 | Healthcare | 18.64% |
| 3 | Industrials | 12.41% |
| 4 | Consumer Discretionary | 10.04% |
| 5 | Utilities | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Baxter International
BAX
$14.3B
| $20.3M | 0.05% |
311,845
-140,700
| -31% | -$9.52M |
|
|
XLRN
377
DELISTED
Acceleron Pharma
XLRN
| $20.2M | 0.05% |
516,073
+24,932
| +5% | +$1.06M |
|
378
Autohome
ATHM
$2.65B
| $20.1M | 0.05% |
234,386
+154,386
| +193% | +$12.6M |
|
|
CA
379
DELISTED
CA, Inc.
CA
| $20.1M | 0.05% |
593,189
-438,179
| -42% | -$15.2M |
|
|
LOXO
380
DELISTED
Loxo Oncology, Inc
LOXO
| $19.9M | 0.05% |
172,301
-48,463
| -22% | -$5.15M |
|
381
CEVA Inc
CEVA
$868M
| $19.8M | 0.05% |
545,916
-77,998
| -13% | -$3.17M |
|
382
Marathon Petroleum
MPC
$94.5B
| $19.8M | 0.05% |
270,142
-16,200
| -6% | -$1.12M |
|
383
International Flavors & Fragrances
IFF
$21.7B
| $19.7M | 0.05% |
143,975
+3,931
| +3% | +$570K |
|
384
Puma Biotechnology
PBYI
$453M
| $19.6M | 0.05% |
+288,480
| New | +$21.6M |
|
|
PTLA
385
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $19.5M | 0.05% |
598,531
-112,203
| -16% | -$4.92M |
|
|
ARNA
386
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $19.4M | 0.05% |
490,684
-71,853
| -13% | -$2.79M |
|
387
Air Products & Chemicals
APD
$68.9B
| $19.3M | 0.05% |
121,104
-3,406
| -3% | -$562K |
|
388
Evolent Health
EVH
$464M
| $19.1M | 0.05% |
1,339,925
+263,548
| +24% | +$3.77M |
|
|
UFS
389
DELISTED
DOMTAR CORPORATION (New)
UFS
| $19.1M | 0.05% |
448,051
-34,388
| -7% | -$1.62M |
|
390
Hormel Foods
HRL
$13.4B
| $19M | 0.05% |
554,317
+38,837
| +8% | +$1.32M |
|
391
TIM SA
TIMB
$8.62B
| $18.8M | 0.05% |
866,562
-585,780
| -40% | -$12.4M |
|
392
Mohawk Industries
MHK
$9.26B
| $18.7M | 0.05% |
80,639
-52,537
| -39% | -$13.5M |
|
393
Huazhu Hotels Group
HTHT
$12.8B
| $18.7M | 0.05% |
567,544
-159,852
| -22% | -$5.85M |
|
|
AVXS
394
DELISTED
AveXis, Inc. Common Stock
AVXS
| $18.6M | 0.05% |
150,381
-45,190
| -23% | -$5.37M |
|
395
Sherwin-Williams
SHW
$88.5B
| $18.5M | 0.05% |
141,438
-3,870
| -3% | -$528K |
|
396
Sonoco
SON
$5.71B
| $18.5M | 0.05% |
380,607
+226,740
| +147% | +$11.5M |
|
397
DexCom
DXCM
$33.8B
| $18.4M | 0.05% |
994,108
-185,836
| -16% | -$2.75M |
|
|
IPHI
398
DELISTED
INPHI CORPORATION
IPHI
| $18.3M | 0.05% |
609,144
-90,660
| -13% | -$2.82M |
|
399
General Dynamics
GD
$106B
| $18.2M | 0.04% |
82,229
-1,600
| -2% | -$348K |
|
400
General Mills
GIS
$20.2B
| $18.1M | 0.04% |
401,398
-33,568
| -8% | -$1.82M |
|
Similar funds
QI
FRBONY
ICOM
BAIA
BPB
BAPIM
PWA
UR
Pictet Asset Management (UK)'s Q1 2018 Portfolio in Review
As of Q1 2018, Pictet Asset Management (UK) held 924 positions worth $40.5B, up 4.3% from $38.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Pictet Asset Management (UK) deployed $1.77B of net new capital in Q1 2018, opening 37 new positions and adding to 379 existing holdings. Its largest new stake was Nektar Therapeutics: 32,593 shares worth $52M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Southern Company, an estimated $105M trimmed.
- Pictet Asset Management (UK)'s largest Q1 2018 buy was Nektar Therapeutics: 32,593 shares worth $52M.
- Pictet Asset Management (UK) added most to Lam Research in Q1 2018, an estimated $154M increase.
- Pictet Asset Management (UK)'s biggest Q1 2018 reduction was Southern Company, cutting an estimated $105M.
- Pictet Asset Management (UK) fully exited Deltic Timber in Q1 2018, selling an estimated $38.8M.
- Pictet Asset Management (UK)'s ten largest holdings make up 12% of its $40.5B portfolio in Q1 2018.
- Pictet Asset Management (UK) opened 37 new positions and closed 31 in Q1 2018.
- Pictet Asset Management (UK)'s portfolio value rose 4.3% quarter-over-quarter to $40.5B.
Based on Pictet Asset Management (UK)'s 13F filing for Q1 2018, filed 25 Apr 2018.